Lucid Diagnostics completes $70 million initial public offering
Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals research, has complete
Source: newswise.com
Stay updated with breaking news from Marshallb Brown. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals research, has complete
Company’s esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals